PortfoliosLab logo

Autolus Therapeutics plc (AUTL)

Equity · Currency in USD · Last updated Sep 3, 2022

Company Info

ISINUS05280R1005
CUSIP05280R100
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.18
Year Range$2.04 - $7.12
EMA (50)$3.18
EMA (200)$3.98
Average Volume$128.18K
Market Capitalization$289.09M

AUTLShare Price Chart


Chart placeholderClick Calculate to get results

AUTLPerformance

The chart shows the growth of $10,000 invested in Autolus Therapeutics plc in Jun 2018 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,272 for a total return of roughly -87.28%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%AprilMayJuneJulyAugustSeptember
-17.19%
-8.26%
AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)

AUTLReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M17.78%-4.08%
6M-13.11%-10.07%
YTD-38.73%-17.66%
1Y-55.52%-13.26%
5Y-38.84%8.80%
10Y-38.84%8.80%

AUTLMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-23.12%-6.27%11.50%-25.18%-12.18%3.28%-1.41%18.28%-3.64%
2021-17.79%-12.38%-11.02%1.57%13.92%0.15%-19.88%29.14%-4.66%-14.81%15.23%-19.28%
2020-25.61%-16.70%-26.77%57.26%32.91%28.04%-17.65%11.14%-20.65%-7.13%-2.96%-14.78%
2019-19.58%3.56%15.06%-16.81%-21.20%-21.96%-4.22%-32.88%20.00%-3.62%25.31%-12.00%
20187.16%-12.36%26.49%3.27%-7.08%36.91%-15.84%

AUTLSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Autolus Therapeutics plc Sharpe ratio is -0.78. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.78
-0.64
AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)

AUTLDividend History


Autolus Therapeutics plc doesn't pay dividends

AUTLDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-93.38%
-18.19%
AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)

AUTLWorst Drawdowns

The table below shows the maximum drawdowns of the Autolus Therapeutics plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Autolus Therapeutics plc is 95.75%, recorded on Jun 15, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.75%Nov 12, 2018904Jun 15, 2022
-27.36%Sep 11, 201823Oct 11, 201820Nov 8, 201843
-24.83%Jun 27, 201812Jul 13, 201821Aug 13, 201833
-5.65%Aug 20, 20184Aug 23, 201810Sep 7, 201814
-0.82%Aug 14, 20181Aug 14, 20181Aug 15, 20182

AUTLVolatility Chart

Current Autolus Therapeutics plc volatility is 43.15%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%AprilMayJuneJulyAugustSeptember
43.15%
21.19%
AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)